UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Day My Gut Feeling Led Me Astray

The New England journal of medicine, 2020-05, Vol.382 (20), p.1880-1881

Noronha, Vanita

2020

Volltextzugriff (PDF)

Making a case for cancer research in India

Cancer Research, Statistics, and Treatment, 2018, Vol.1 (1), p.71-74

Noronha, Vanita

2018

Volltextzugriff (PDF)

Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial

Journal of clinical oncology, 2021-04, Vol.39 (11), p.1234-1242

2021

Volltextzugriff (PDF)

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR -Mutated Lung Cancer

Journal of clinical oncology, 2020-01, Vol.38 (2), p.124-136

2020

Volltextzugriff (PDF)

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data

The oncologist (Dayton, Ohio), 2017-09, Vol.22 (9), p.1056-1066

2017

Volltextzugriff (PDF)

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

Cancer, 2019-09, Vol.125 (18), p.3184-3197

2019

Volltextzugriff (PDF)

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

Frontiers in oncology, 2019-02, Vol.9, p.86-86

2019

Volltextzugriff (PDF)

Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab

British journal of cancer, 2020-12, Vol.123 (12), p.1757-1766

2020

Volltextzugriff (PDF)

Cancer incidence estimates in adults aged 60 years and older living in low-and-middle-income countries for the years 2020 and 2040

Ecancermedicalscience, 2023-08, Vol.17, p.1594-1594

2023

Volltextzugriff (PDF)

Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab

British journal of cancer, 2022-06, Vol.126 (10), p.1439-1449

2022

Volltextzugriff (PDF)

Authors’ reply to Thota and Seshadri

Cancer research, statistics, and treatment (Online), 2024-01, Vol.7 (1), p.145-146

2024

Volltextzugriff (PDF)

Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity

PloS one, 2013-10, Vol.8 (10), p.e76164-e76164

2013

Volltextzugriff (PDF)

Patient advocacy and support groups in India: focus on lung cancer

The Lancet regional health. Southeast Asia, 2024-08, Vol.27, p.100429, Article 100429

2024

Volltextzugriff (PDF)

Authors' reply to Maskomani

Cancer research, statistics, and treatment (Online), 2023-04, Vol.6 (2), p.349-350

2023

Volltextzugriff (PDF)

Authors' reply to Saleem et al

Cancer research, statistics, and treatment (Online), 2023-04, Vol.6 (2), p.342-342

2023

Volltextzugriff (PDF)

Authors' reply to Bhattacharya

Cancer research, statistics, and treatment (Online), 2023-04, Vol.6 (2), p.344-345

2023

Volltextzugriff (PDF)

Weekly osimertinib dosing prevents EGFR mutant tumor cells destined to home mouse lungs

Translational oncology, 2021-08, Vol.14 (8), p.101111-101111, Article 101111

2021

Volltextzugriff (PDF)

Authors' reply to Bhargav and Mayilvaganan

Cancer research, statistics, and treatment (Online), 2023-01, Vol.6 (1), p.171-172

2023

Volltextzugriff (PDF)

Editorial: Site specific imaging guidelines in head & neck, and skull base cancers

Frontiers in oncology, 2024, Vol.14, p.1357215-1357215

2024

Volltextzugriff (PDF)

Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non–small cell lung cancer (NSCLC) with brain metastases

European journal of clinical pharmacology, 2020-10, Vol.76 (10), p.1427-1436

2020

Volltextzugriff (PDF)

Authors' reply to Shah and Sahu

Cancer research, statistics, and treatment (Online), 2023-07, Vol.6 (3), p.489-490

2023

Volltextzugriff (PDF)

Lung cancer in the Indian subcontinent

South Asian journal of cancer, 2016-07, Vol.5 (3), p.095-103

2016

Volltextzugriff (PDF)

Amivantamab: A narrative drug review

Cancer research, statistics, and treatment (Online), 2023-04, Vol.6 (2), p.261-271

2023

Volltextzugriff (PDF)

EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy

PloS one, 2013-04, Vol.8 (4), p.e61561

2013

Volltextzugriff (PDF)

1 – 25 von 619

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(583)
Mit Volltextzugriff
(570)

Publikationsform

Sprache

Englisch
(619)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(20)

Menü

Weitere Dienste

Einstellungen

The Day My Gut Feeling Led Me Astray

Making a case for cancer research in India

Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR -Mutated Lung Cancer

Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab

Cancer incidence estimates in adults aged 60 years and older living in low-and-middle-income countries for the years 2020 and 2040

Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab

Authors’ reply to Thota and Seshadri

Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity

Patient advocacy and support groups in India: focus on lung cancer

Authors' reply to Maskomani

Authors' reply to Saleem et al

Authors' reply to Bhattacharya

Weekly osimertinib dosing prevents EGFR mutant tumor cells destined to home mouse lungs

Authors' reply to Bhargav and Mayilvaganan

Editorial: Site specific imaging guidelines in head & neck, and skull base cancers

Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non–small cell lung cancer (NSCLC) with brain metastases

Authors' reply to Shah and Sahu

Lung cancer in the Indian subcontinent

Amivantamab: A narrative drug review

EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy

Suchergebnisse filtern